Top Tweets for #TCellEngager
#OnlineFirst: Identification and Non-clinical Characterization of SAR444200, a Novel Anti-GPC3 #NANOBODY® T-cell Engager, for the Treatment of #GPC3+ #SolidTumors https://t.co/yY6fcatHz9
@sanofi #FirstDisclosure #TCellEngager #OpenAccess

Abpro unveiled preclinical data for ABP-102/CT-P72 at #AACR25. This HER2 x CD3 #TCellEngager showed potent tumor killing, reduced cytokine release & improved tolerability—supporting its potential as best-in-class.
More info: https://t.co/KRY6n294Dk
$ABP

#ESMO22 Updates: IMC-F106C (PRAME×CD3) show encouraging responses in heavily pre-treated pts esp. in cutaneous and uveal melanoma – represents larger opportunities for development and further validation
#solidtumors #oncology #immunotherapy #tcellengager #bispecifics

Numab will present novel preclinical data on its #ROR1-targeting antibody NM32-2668 at #SITC2021. Check out the SITC website or our website on Friday November 12th to learn more about the tri-specific ROR1xCD3xHSA #TcellEngager.

💥Hats off to @DanChenMDPhD! Great talk & Amazing job driving panel discussion @sitcancer #TCellEngager #TCE #DART #TCB #BiTEs Workshop. Great fun participating on panel with Dan and Dr Rafi Ahmed! Almost felt like we were in the same room! ONLY 41 DAYS UNTIL SITC! #FinishCancer

Breaking news out of @Amgen today 🚨
https://t.co/2UiZAWw4K1
#biotech #MultipleMyeloma #bispecifics #tcellengager #clinicaltrial
Thank you to @BCD_AACR for creating this cover art featuring our research #Tcellengager #greekmythology
@DRSNmoonshot PIs @Leif_Bergsagel,@erinmeermeier & team @MayoClinic work features "on the cover" @BCD_AACR -responses to bispecific T-cell engager (BiTE) antibody therapy of myeloma, limited by T cell exhaustion can be overturned by adding cyclophosphamide https://t.co/AidIiDrZ9r

ICYMI: Read here about a #bispecific #antibody that can unleash #γδTcell–mediated #AntitumorResponses against both #leukemia and #MultipleMyeloma.
#CD40 #TcellEngager
https://t.co/6xVGWucgkv

Read here about a #bispecific #antibody that can unleash #γδTcell–mediated #AntitumorResponses against both #leukemia and #MultipleMyeloma.
#CD40 #TcellEngager
https://t.co/ZjnP9l4xHu

#ImmuneCheckpoint inhibitors, #TCellEngager #antibodies #CART: new types of immunotherapies for the management of patients with lymphoma @Annals_Oncology https://t.co/TO2XmTm1RA

Last Seen Hashtags on Sotwe
Most Popular Users

Elon Musk 
@elonmusk
240.9M followers

Barack Obama 
@barackobama
119.2M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Cristiano Ronaldo 
@cristiano
111.5M followers

Narendra Modi 
@narendramodi
107.1M followers

Rihanna 
@rihanna
97.9M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.1M followers

KATY PERRY 
@katyperry
88.2M followers

Taylor Swift 
@taylorswift13
82M followers

Lady Gaga 
@ladygaga
73.6M followers

Virat Kohli 
@imvkohli
70.7M followers

Kim Kardashian 
@kimkardashian
70M followers

YouTube 
@youtube
68.7M followers

Bill Gates 
@billgates
64.2M followers

Neymar Jr 
@neymarjr
63.5M followers

The Ellen Show
@theellenshow
62.4M followers

CNN 
@cnn
61.9M followers

Selena Gomez 
@selenagomez
61.3M followers

X 
@x
60.8M followers










